Abstract
From its known properties “soframycin” appears to be valuable for intestinal antisepsis since it has a broad spectrum. The intestinal bacteria are sensitive to it, it acts rapidly, is poorly absorbed from the gastrointestinal tract, and is well tolerated by mouth.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CONNELL J. F., Jr, ROUSSELOT L. M. Preliminary studies on a new intestinal bactericide; soframycin. Surgery. 1958 Sep;44(3):447–452. [PubMed] [Google Scholar]
- LOUWETTE R., LAMBRECHTS A. Framycetin in infantile gastroenteritis due to pathogenic Escherichia coli. Br Med J. 1958 Apr 12;1(5075):868–869. doi: 10.1136/bmj.1.5075.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LUTZ A., HOFFERER M. J. L'action in vitro de quelques antibiotiques et de l'association chloramphénicol-framycétine sur divers types de Salmonella. Strasb Med. 1955 Nov;6(11):633–641. [PubMed] [Google Scholar]
- MARQUEZY R. A., DEBRAY P., LEVEAU, GRENIER, LEPAGE Action de la framycétine seule ou associée à la chloromycétine sur les gastro-entéro-colites à Escherichia coli 111 B4-55 B5-26 B6. Arch Fr Pediatr. 1955;12(8):859–861. [PubMed] [Google Scholar]